Scientific Background
Survodutide is a GLP-1/glucagon dual agonist researched for aggressive metabolic support, appetite regulation, and increased energy expenditure.
Mechanism of Action (Informational Only)

• GLP-1 receptor activation
• Glucagon receptor stimulation
• May enhance metabolic rate in research models

Potential Functional Benefits

• Often selected for obesity-related research
• Supports fat-oxidation studies
• Popular in next-generation weight-loss research

Vial Contents

• 10mg Survodutide

Notes
For research and educational purposes only.